Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#What Is the Estimated Market Size of the DNA Testing Market In 2029?#_x000D_
In the past few years, the size of the dna testing market has seen substantial growth. The market size is projected to expand from $17.9 billion in 2024 to $20.04 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. Factors that contributed to growth during the historic period include a surge in chronic disease cases, an increased need for precision medicine, a growth in direct-to-consumer (DTC) testing, a surge in demand for population genomics, an expansion in forensic investigations, and a growing requirement for genetic screening._x000D_
_x000D_
In the forthcoming years, the dna testing market is set to experience significant growth, with anticipated expansion to $30.25 billion by 2029 at a compound annual growth rate (CAGR) of 10.8%. The upcoming growth can be linked to an increase in genetic diseases, the escalating use of DNA diagnostics, improvements in healthcare infrastructure, heightened disease prevention awareness, growing investment from manufacturers, and widening acceptance of companion diagnostics. Emerging trends for the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in conjunction with assisted reproductive technologies (ART), the miniaturization of testing equipment, introduction of new DNA testing products, and the creation of innovative assays, biomarkers, diagnostic instruments, point-of-care testing, and non-invasive prenatal testing (NIPT)._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp_x000D_
_x000D_
#What Are the Major Market Drivers Behind the Rising Adoption of DNA Testing Market?#_x000D_
The rise in genetic disorders is projected to stimulate the expansion of the DNA testing market. Genetic disorders result from abnormalities in an individual’s DNA, causing physical or developmental anomalies. The escalating occurrence of these disorders can be linked to heightened awareness, enhanced diagnostic methods, comprehensive genetic screening, and an upward trend in consanguineous marriages in certain populations. DNA testing plays a growing role in diagnosing, prognosing, and determining treatment for individuals with genetic disorders, facilitating personalized healthcare and family planning strategies based on one’s genetic composition. For example, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations, reported in February 2023 that congenital diseases accounted for an estimated 240,000 infant mortalities globally within the first 28 days of birth each year. Additionally, the Centers for Disease Control and Prevention, a U.S. government agency, reported that about 6,000 babies are born with Down syndrome in the United States yearly, or roughly 1 in every 700 babies. As such, the ascending prevalence of genetic disorders is fueling the DNA testing market._x000D_
_x000D_
#Which Key Market Segments Comprise the DNA Testing Market and Drive Its Revenue Growth?#_x000D_
The dna testingmarket covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Equipment; Consumables; Software And Services_x000D_
2) By Technology: Polymerase Chain Reaction (PCR) Based; In-Situ Hybridization; Microarray; Next-Generation Sequencing (NGS) DNA Diagnosis_x000D_
3) By Application: Newborn DNA Screening; Pre-Natal DNA Carrier Screening; Oncology Diagnostics And Histopathology; Pre-implantation Diagnosis; Infectious Disease Diagnostics; Pharmacogenomics Diagnostic Testing; Identify Diagnostics And Forensic; Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Equipment: DNA Analyzers; PCR (Polymerase Chain Reaction) Machines; Sequencers; Electrophoresis Systems; Other DNA Testing Instruments_x000D_
2) By Consumables: Reagents And Kits; PCR Consumables (Primers, Probes); DNA Extraction Kits; Sample Collection Devices; Others (DNA Markers, Electrophoresis Gels)_x000D_
3) By Software: Data Analysis Software; Laboratory Information Management System (LIMS); Genetic Analysis Software; Bioinformatics Software; Other DNA Testing Software Solutions_x000D_
4) By Services: Testing Services (Genetic Testing, Forensic Testing, Etc.); Data Interpretation Services; Consultation Services (Genetic Counseling); Laboratory Services (Sample Processing, DNA Sequencing Services); Other DNA Testing Services_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=15358&type=smp_x000D_
_x000D_
#Which Areas Are Leading Regions in the DNA Testing Market Expansion Across the Globe?#_x000D_
North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Are the Strategic Trends Steering theDNA Testing Market Direction?#_x000D_
Leading firms in the DNA testing industry are concentrating on the creation of advanced examination solutions like DNA tests for precancer detection in order to enhance early cancer diagnosis and treatment. These precancer detection DNA tests are diagnostic procedures created to pinpoint genetic modifications or biomarkers linked with the initial phases of cancer progression. For example, in November 2023, Lucid Diagnostics Inc., an American company focused on preventing esophageal cancer, introduced a state-of-the-art esophageal EsoGuard DNA Test, dubbed EsoGuard 2.0. This sophisticated exam employs molecular methods and amplifies sample DNA yields to improve test execution and lower expenses. The procedure involves collecting esophageal cell DNA through the EsoCheck Cell Collection Device, which is followed by bisulfite conversion, PCR amplification, and then next-generation sequencing to detect methylation at specific sites on genes associated with esophageal precancer and cancer. This DNA test results in signifies the presence or absence of epigenetic changes aligning with esophageal precancer and cancer, thereby making it a vital tool in the early detection and prevention of cancer._x000D_
_x000D_
#View the full report here:#_x000D_
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report_x000D_
_x000D_
#How Is the DNA Testing Market Conceptually Defined?#_x000D_
Deoxyribonucleic acid (DNA) testing refers to the process of analyzing an individual’s DNA, that carries the instructions for an organism’s development, functioning, and traits. It involves extracting DNA from cells, typically obtained from bodily fluids or tissues like blood, saliva, or hair, and then examining specific regions or sequences of the DNA molecule._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15358_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model